07:46 AM EDT, 07/01/2025 (MT Newswires) -- Nektar Therapeutics ( NKTR ) said Tuesday it priced a public offering of 4,255,320 common shares at $23.50 each for about $100 million in expected gross proceeds.

Underwriters have a 30-day overallotment option to buy up to 638,298 additional shares.

The company expects the offering to close Wednesday and plans to use the net proceeds for general corporate purposes.